Changes in diet, cardiovascular risk factors and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort

Diabetic Medicine

Volumn 31, Issue 2, 2014, Pages 148-155

  Savory, L A ^a   Griffin, S J ^a   Williams, K M ^a   Prevost, A T ^a,b   Kinmonth, A L ^a   Wareham, N J ^a   Simmons, R K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; CHOLESTEROL; FAT; HEMOGLOBIN A1C; SODIUM;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CACAO; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; DIETARY INTAKE; DISEASE ASSOCIATION; ENERGY METABOLISM; FAT INTAKE; FEMALE; FIBER; FOOD INTAKE; FRUIT; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PLUM; RISK ASSESSMENT; SODIUM INTAKE; VEGETABLE; VITAMIN BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; FEEDING BEHAVIOR; HEALTH CARE QUALITY; LIFESTYLE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; FOOD HABITS; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; STANDARD OF CARE; TREATMENT OUTCOME;

EID: 84892535613     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12316     Document Type: Article

References (31)

1. IDF. The Diabetes Atlas. 4th edition. Brussels: International Diabetes Federation, 2009.
2. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997; 5: 294-315.
3. Diabetes UK. Evidence-Based Nutrition Guidelines for the Prevention and Management of Diabetes. London: Diabetes UK, 2011. Available at http://www.diabetes.org.uk/Documents/Reports/Nutritional_guidelines200911.pdf Last accessed 10 July 2012.
4. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG et al. American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31: S61-78.
5. Gillies CL, Abrams KR, Lambert PC, Cooper NJ, Sutton AJ, Hsu RT, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. Br Med J 2007; 334: 299.
6. Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010; 170: 1566-1575.
7. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
8. Andrews RC, Cooper AR, Montgomery AA, Norcross AJ, Peters TJ, Sharp DJ et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet 2011; 378: 129-139.
9. Davies MJ, Heller S, Skinner TC, Campbell MJ, Carey ME, Cradock S et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. Br Med J 2008; 336: 491-495.
10. National Screening Committee. Handbook for Vascular Risk Assessment, Risk Reduction and Risk Management. University of Leicester: National Screening Committee, 2008.
11. Echouffo-Tcheugui JB, Simmons RK, Williams KM, Barling RS, Prevost AT, Kinmonth AL et al. The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health 2009; 9: 136.
12. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
13. Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM, Prevost AT et al. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabet Med 2010; 27: 995-1003.
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
15. Griffin SJ, Borch-Johnsen K, Davies MJ, Khunti K, Rutten GE, Sandbaek A et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 2011; 378: 156-167.
16. McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A et al. Clinical Guidelines and Evidence for Type 2 Diabetes: Management of Blood Pressure. Sheffield: University of Sheffield, 2002.
17. McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A et al. Clinical Guidelines and Evidence for Type 2 Diabetes: Lipids Management. Sheffield: University of Sheffield, 2002.
18. McIntosh A, Hutchinson A, Home PD, Brown F, Bruce A, Damerell A et al. Clinical Guidelines and Evidence Review for Type 2 Diabetes: Management of Blood Glucose. Sheffield: University of Sheffield, 2001.
19. Coleman R, Stevens R, Holman R, eds. The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals With or Without Type 2 Diabetes. Chicago: American Diabetic Association, 2007.
20. Bingham SA, Gill C, Welch A, Cassidy A, Runswick SA, Oakes S et al. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997; 26: S137-151.
21. Wareham NJ, Jakes RW, Rennie KL, Mitchell J, Hennings S, Day NE. Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol 2002; 31: 168-174.
22. Forouhi NG, Sharp SJ, Du H, van der AD, Halkjaer J, Schulze MB et al. Dietary fat intake and subsequent weight change in adults: results from the European Prospective Investigation into Cancer and Nutrition cohorts. Am J Clin Nutr 2009; 90: 1632-1641.
23. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
24. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
25. Harding AH, Wareham NJ, Bingham SA, Khaw K, Luben R, Welch A et al. Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European Prospective Investigation of Cancer-Norfolk prospective study. Arch Intern Med 2008; 168: 1493-1499.
26. Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with Type 2 diabetes. Diabetes Care 2011; 34: 1481-1486.
27. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006; 29: 2102-2107.
28. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999; 353: 617-622.
29. Schaefer EJ, Augustin JL, Schaefer MM, Rasmussen H, Ordovas JM, Dallal GE et al. Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr 2000; 71: 746-751.
30. Kristal AR, Beresford SA, Lazovich D. Assessing change in diet-intervention research. Am J Clin Nutr 1994; 59: 185S-189S.
31. McKeown NM, Day NE, Welch AA, Runswick SA, Luben RN, Mulligan AA et al. Use of biological markers to validate self-reported dietary intake in a random sample of the European Prospective Investigation into Cancer UK Norfolk cohort. Am J Clin Nutr 2001; 74: 188-196.